Journal
PHARMACEUTICAL RESEARCH
Volume 27, Issue 5, Pages 767-774Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-010-0067-0
Keywords
ischemic hindlimb model; localized delivery; microsphere/hydrogel combination system; therapeutic angiogenesis; vascular endothelial growth factor
Funding
- Korean Government [2009-K001598, 2009-0065528]
- Ministry of Education, Science and Technology, Republic of Korea [200900000000024]
Ask authors/readers for more resources
We hypothesize that the controlled delivery of rhVEGF using a microsphere/hydrogel combination system could be useful to achieve active blood vessel formation in the ischemic hindlimb mouse model, which is clinically relevant for therapeutic angiogenesis without multiple administrations. A combination of poly(d,l-lactide-co-glycolide) (PLGA) microspheres and alginate hydrogels containing rhVEGF was prepared and injected intramuscularly into the ischemic hindlimb site of mouse model, and new blood vessel formation near the ischemic site was evaluated. The controlled release of rhVEGF from the combination system effectively protected muscles in ischemic regions from tissue necrosis. Interestingly, the number of newly formed, active blood vessels was significantly increased in mice treated with the rhVEGF-releasing combination system. A microsphere/hydrogel combination system provided a useful means to deliver therapeutic angiogenic molecules into the body for the treatment of ischemic vascular diseases, which could reduce the number of administrations of many types of drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available